Probenecid for Gout: Opening the Drain

Picture the uric acid in your blood as water in a sink. Two things decide how high it rises: how fast the tap runs, and how open the drain is. Most urate-lowering medicines, allopurinol among them, work on the tap. Probenecid is the one that works on the drain.

Uric acid leaves your body mostly through your kidneys, and your kidneys are thrifty. They filter uric acid out, then quietly reabsorb much of it back into the blood before it ever reaches your urine. Probenecid blocks that reabsorption. It acts on the transport proteins that pull uric acid back in, including one called URAT1, so more of it simply drains away².

The goal is the same as with any urate-lowering treatment: get your serum urate below 6 mg/dL and hold it there. That is the level at which the crystals already sitting in your joints start to dissolve and new ones stop forming¹.

For most people with gout, the problem was never how much uric acid they make. It is how little their kidneys let go of. The body under-excretes, urate creeps up over years, and eventually it crystallizes. That is biology, not a grocery list, and it is exactly the mechanism a drug that opens the drain is built to address.

Even so, probenecid is usually not the first medicine reached for. Allopurinol tends to be the starting point for most people, and probenecid comes into the conversation when a xanthine oxidase inhibitor is not the right fit and when the kidneys are working well enough to handle the extra load. Whether it belongs in your plan is a decision for you and your clinician together.

Probenecid is a tablet taken every day. It is typically started at a low dose, around 500 mg once or twice daily, then increased gradually while your uric acid is rechecked, until your level reaches target³. The exact dose is something your clinician sets and adjusts for you.

One thing to be clear about: probenecid does nothing for the flare you are in tonight. It is not a painkiller, and it does not calm inflammation. Like every urate-lowering medicine, it works slowly and quietly in the background. The payoff shows up as flares that stop arriving, not as pain that eases within the hour.

Opening the drain has a trade-off. When probenecid sends more uric acid through your kidneys and out into your urine, that urine is carrying a heavier load. In some people, that extra load can encourage kidney stones to form.

This is why people on a drain-opening medicine are usually asked to drink plenty of fluids. Staying well hydrated keeps the urine dilute and keeps the urate moving through rather than settling. It is a small daily habit that does real work, and it is worth asking your clinician what they would like you to aim for.

Probenecid leans on your kidneys to do its job, so it needs kidneys that are up to the task. When kidney function is meaningfully reduced, the drug simply does not work as well. For people with chronic kidney disease at stage 3 or worse, the guideline strongly prefers a xanthine oxidase inhibitor, such as allopurinol, over probenecid⁴.

Probenecid is also something of a blunt instrument. It blocks the transport of a range of substances, not only uric acid, which means it can interfere with other medicines your kidneys handle. That lack of selectivity, and the drug interactions that come with it, are part of what limits how widely it gets used².

Because probenecid and allopurinol work on different halves of the same sink, one on the drain and one on the tap, they can in principle be used together to push stubborn uric acid down toward target.

It is worth knowing that the guideline does not reach for that pairing first. When a first xanthine oxidase inhibitor has not gotten someone to target at its full dose, the conditionally recommended next step is usually to switch to a second one rather than add a uricosuric like probenecid⁵. Adding probenecid is a considered option for particular situations, not the default. It is a conversation for a clinician who can weigh your kidneys, your other medicines, and how far you still are from the goal line.